Regulation of lupus pathogenesis through modulation of thymic development of pathobiont-specific T cells
通过调节病原体特异性 T 细胞的胸腺发育来调节狼疮发病机制
基本信息
- 批准号:10525740
- 负责人:
- 金额:$ 9.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAntigensAttentionAutoantigensAutoimmune DiseasesAutoimmunityB-LymphocytesBacteriaBacterial TranslocationCell Differentiation processCellsChronicCommunicationDataDevelopmentDiseaseDisease ProgressionDisease modelDoctor of PhilosophyEnsureExhibitsFoundationsGenerationsGoalsImmune responseImmune systemImmunologyIndividualInflammationInflammatoryIntestinal permeabilityIntestinesKnowledgeLaboratoriesLactobacillus reuteriLinkLiverLupusMediatingMemorial Sloan-Kettering Cancer CenterMentorsModelingMusOrganPathogenesisPathogenicityPathologyPathway interactionsPatientsPeripheralPostdoctoral FellowPredispositionProcessProductionRegulationResearchResearch InstituteResearch PersonnelResearch SupportRoleSchoolsSiteSpleenSupervisionSystemic Lupus ErythematosusT cell responseT-Cell DevelopmentT-LymphocyteTechnical ExpertiseTechniquesTestingTherapeuticThymus GlandTissuesTrainingWeaningWild Type MouseWorkadaptive immune responseantigen-specific T cellsbasecareercareer developmentdesigndysbiosiseffector T cellgut inflammationgut microbesgut microbiotahost-microbe interactionsimprovedinnate immune pathwayslupus prone micemesenteric lymph nodemicrobial colonizationmicrobiotamouse modelpathobiontpost-doctoral trainingprogramsprophylacticresearch and developmentresponseskillssystemic inflammatory response
项目摘要
PROJECT SUMMARY/ABSTRACT
CANDIDATE: I am a postdoctoral research associate in the laboratory of Dr. Gretchen E. Diehl in the
Immunology Program at Memorial Sloan-Kettering Cancer Center. I obtained my PhD working in gut
microbiota and systemic lupus erythematosus under the supervision of Dr. Martin Kriegel. My current research
applies the techniques I learned in my postdoc and graduate school to assess the role of gut microbes in the
thymic development of microbiota-specific T cells and how these T cells can modulate disease in susceptible
hosts. To elucidate this process, I used a tetramer-based approach to identify and track antigen-specific T cells
expansion in the thymus before they distribute and differentiate in the periphery. I plan to study how this
process is altered in autoimmunity. My proposed research and mentoring plan will provide me the required
foundation to transition into an independent researcher with a long-term career goal to understand how
microbiota-specific T cell responses arise and define how they exacerbate lupus pathogenesis. To achieve this
goal, together with my mentoring team, I have developed a career plan that will 1) increase my technical skills,
2) refine my scientific scope, 3) improve my communication skills, and 4) expand my scientific network.
RESEARCH: Lupus development is associated with intestinal dysbiosis in patients and mouse models.
Dysbiosis in lupus is characterized by pathobiont overgrowth and is linked to dysregulated immune responses
that exacerbate pathogenesis. In my graduate work, I found increased pathobionts including Lactobacillus
reuteri in mouse lupus models and subsets of SLE patients. I showed L. reuteri translocated systemically,
leading to increased inflammatory pathways and proinflammatory T cells which exacerbated systemic
inflammation and worsened lupus pathogenesis. In my postdoctoral work, I am investigating how differentiation
of microbiota-specific T cells is regulated during development and its effects in inflammatory processes. While
we and others find peripheral expansion of microbiota-specific T cells with effector function in adult mice, in
young mice we surprisingly found microbiota-specific T cells first expanded in the thymus, a site not previously
known to allow for antigen-specific T cell expansion. I aim to synergize the knowledge generated during my
graduate and postdoctoral training to determine if thymic development of L. reuteri-specific T cells is amplified
in lupus susceptible hosts and to assess their role in lupus exacerbation. I will develop this proposal by 1)
Determining how thymic microbiota-specific T cells modulate lupus pathogenesis and 2) Defining how lupus
pathobionts modulate pathobiont-specific T cells expansion.
ENVIRONMENT: The laboratory is part of the Immunology program at Memorial Sloan-Kettering Cancer
Center, a state-of-the-art research institute. Furthermore, my mentoring committee and collaborators will
provide the required scientific and non-scientific support for the research and career development proposed.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Fernando Zegarra Ruiz其他文献
Daniel Fernando Zegarra Ruiz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Fernando Zegarra Ruiz', 18)}}的其他基金
Regulation of lupus pathogenesis through modulation of thymic development of pathobiont-specific T cells
通过调节病原体特异性 T 细胞的胸腺发育来调节狼疮发病机制
- 批准号:
10665758 - 财政年份:2022
- 资助金额:
$ 9.19万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 9.19万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 9.19万 - 项目类别:














{{item.name}}会员




